BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33771355)

  • 1. Radiotherapy for locally advanced pancreatic ductal adenocarcinoma.
    Buss EJ; Kachnic LA; Horowitz DP
    Semin Oncol; 2021 Feb; 48(1):106-110. PubMed ID: 33771355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of imaging in the clinical practice of radiation oncology for pancreatic cancer.
    Koay EJ; Hall W; Park PC; Erickson B; Herman JM
    Abdom Radiol (NY); 2018 Feb; 43(2):393-403. PubMed ID: 29110053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablative radiation therapy for locally advanced pancreatic cancer: techniques and results.
    Reyngold M; Parikh P; Crane CH
    Radiat Oncol; 2019 Jun; 14(1):95. PubMed ID: 31171025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Stereotactic Body Radiation Therapy Be a Viable and Efficient Therapeutic Option for Unresectable Locally Advanced Pancreatic Adenocarcinoma? Results of a Phase 2 Study.
    Comito T; Cozzi L; Clerici E; Franzese C; Tozzi A; Iftode C; Navarria P; D'Agostino G; Rimassa L; Carnaghi C; Personeni N; Tronconi MC; De Rose F; Franceschini D; Ascolese AM; Fogliata A; Tomatis S; Santoro A; Zerbi A; Scorsetti M
    Technol Cancer Res Treat; 2017 Jun; 16(3):295-301. PubMed ID: 27311310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART).
    Bryant JM; Palm RF; Herrera R; Rubens M; Hoffe SE; Kim DW; Kaiser A; Ucar A; Fleming J; De Zarraga F; Hodul P; Aparo S; Asbun H; Malafa M; Jimenez R; Denbo J; Frakes JM; Chuong MD
    Cancer Control; 2023; 30():10732748221150228. PubMed ID: 36598464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablative Radiotherapy Doses for Locally Advanced: Pancreatic Cancer (LAPC).
    Crane CH; O'Reilly EM
    Cancer J; 2017; 23(6):350-354. PubMed ID: 29189331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma-A Critical Review of Randomised Trials.
    Ejlsmark MW; Schytte T; Bernchou U; Bahij R; Weber B; Mortensen MB; Pfeiffer P
    Curr Oncol; 2023 Jul; 30(7):6820-6837. PubMed ID: 37504359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated ablative radiotherapy for locally advanced pancreatic cancer.
    Crane CH
    J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i53-i57. PubMed ID: 27029741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation.
    Zhong J; Patel K; Switchenko J; Cassidy RJ; Hall WA; Gillespie T; Patel PR; Kooby D; Landry J
    Cancer; 2017 Sep; 123(18):3486-3493. PubMed ID: 28493288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic MR-guided online adaptive radiotherapy reirradiation (SMART reRT) for locally recurrent pancreatic adenocarcinoma: A case report.
    Doty DG; Chuong MD; Gomez AG; Bryant J; Contreras J; Romaguera T; Alvarez D; Kotecha R; Mehta MP; Gutierrez AN; Mittauer KE
    Med Dosim; 2021 Winter; 46(4):384-388. PubMed ID: 34120803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma.
    Simoni N; Micera R; Paiella S; Guariglia S; Zivelonghi E; Malleo G; Rossi G; Addari L; Giuliani T; Pollini T; Cavedon C; Salvia R; Milella M; Bassi C; Mazzarotto R
    Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):e31-e38. PubMed ID: 32682686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic body radiotherapy (SBRT) for patients with locally advanced pancreatic cancer: A single center experience.
    Jumeau R; Delouya G; Roberge D; Donath D; Béliveau-Nadeau D; Campeau MP
    Dig Liver Dis; 2018 Apr; 50(4):396-400. PubMed ID: 29326012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
    Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
    Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).
    Pavic M; Niyazi M; Wilke L; Corradini S; Vornhülz M; Mansmann U; Al Tawil A; Fritsch R; Hörner-Rieber J; Debus J; Guckenberger M; Belka C; Mayerle J; Beyer G
    Radiat Oncol; 2022 Jan; 17(1):18. PubMed ID: 35078490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer.
    Oar A; Lee M; Le H; Wilson K; Aiken C; Chantrill L; Simes J; Nguyen N; Barbour A; Samra J; Sjoquist KM; Moore A; Espinoza D; Gebski V; Yip S; Chu J; Kneebone A; Goldstein D
    BMC Cancer; 2021 Aug; 21(1):936. PubMed ID: 34412605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of intraluminal brachytherapy using
    Yang M; Yan Z; Luo J; Liu Q; Zhang W; Ma J; Zhang Z; Yu T; Zhao Q; Liu L
    Brachytherapy; 2016; 15(6):859-864. PubMed ID: 27364870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic radiotherapy and the potential role of magnetic resonance-guided adaptive techniques for pancreatic cancer.
    Ermongkonchai T; Khor R; Muralidharan V; Tebbutt N; Lim K; Kutaiba N; Ng SP
    World J Gastroenterol; 2022 Feb; 28(7):745-754. PubMed ID: 35317275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiotherapy in the treatment of pancreatic cancer.
    Trakul N; Koong AC; Chang DT
    Semin Radiat Oncol; 2014 Apr; 24(2):140-7. PubMed ID: 24635871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery.
    Mazzola R; Fersino S; Aiello D; Gregucci F; Tebano U; Corradini S; Di Paola G; Cirillo M; Tondulli L; Ruffo G; Ruggieri R; Alongi F
    Strahlenther Onkol; 2018 Sep; 194(9):835-842. PubMed ID: 29696321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Stereotactic Body Radiotherapy in the Treatment of Elderly and Poor Performance Status Patients With Pancreatic Cancer.
    Rosati LM; Herman JM
    J Oncol Pract; 2017 Mar; 13(3):157-166. PubMed ID: 28282277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.